Início › Câncer de Ovário › Califórnia › Mountain View
Ensaios clínicos de Câncer de Ovário em Mountain View, CA
19 estudos para Câncer de Ovário estão buscando participantes em locais em Mountain View e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RecrutandoFase 2/3
- Stanford Cancer Institute Palo Alto, Palo Alto · a 5 mi de distância
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · a 5 mi de distância
- VA Palo Alto Health Care System, Palo Alto · a 5 mi de distância
A Study of PHST001 in Advanced Solid Tumors
RecrutandoFase 1
- Stanford University School of Medicine, Palo Alto · a 5 mi de distância
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecrutandoEstudo observacional
- Stanford University, Palo Alto · a 5 mi de distância
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecrutandoFase 3
- Stanford Women's Cancer Center, Palo Alto · a 5 mi de distância
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecrutandoFase 1
- Stanford University Medical Center, Stanford · a 5 mi de distância
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- Stanford Cancer Institute, Stanford · a 5 mi de distância
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
RecrutandoFase 1
- Stanford University, Palo Alto · a 5 mi de distância
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RecrutandoFase 1
- Stanford, Palo Alto · a 5 mi de distância
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecrutandoFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · a 5 mi de distância
- e mais 1
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecrutandoFase 2
- 150, Palo Alto · a 5 mi de distância
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecrutandoFase 3
- Palo Alto Medical Foundation, Palo Alto · a 5 mi de distância
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- Stanford University, Stanford · a 5 mi de distância
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RecrutandoFase 1/2
- Stanford Women's Cancer Center, Palo Alto · a 5 mi de distância
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
RecrutandoEstudo observacional
- Stanford University School of Medicine, Stanford · a 5 mi de distância
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RecrutandoFase 1/2
- Stanford Cancer Institute, Stanford · a 5 mi de distância
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RecrutandoFase 3
- Stanford Ambulatory Surgery Center Lane Operating Room, Palo Alto · a 5 mi de distância
- Stanford Women's Cancer Center, Palo Alto · a 5 mi de distância
- Stanford Hospital, Palo Alto · a 5 mi de distância
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RecrutandoFase 2
- Stanford Cancer Center, Palo Alto · a 5 mi de distância
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Stanford · a 5 mi de distância
Ensaios de Câncer de Ovário em outras cidades
- Houston, TX89 estudos
- New York City, NY69 estudos
- Boston, MA61 estudos
- Los Angeles, CA50 estudos
- Nashville, TN49 estudos
- Arlington, VA46 estudos
- Philadelphia, PA44 estudos
- Columbus, OH39 estudos
- St. Louis, MO38 estudos
- Chicago, IL36 estudos
- San Antonio, TX31 estudos
- Cleveland, OH30 estudos
Outros estudos em Mountain View
- Câncer (todos os tipos)40 estudos
- Câncer de Mama26 estudos
- Câncer Metastático25 estudos
- Câncer de Pulmão de Não Pequenas Células21 estudos
- Leucemia Mieloide Aguda19 estudos
- Transtorno do Espectro Autista17 estudos
- Câncer de Pulmão17 estudos
- Câncer de Próstata15 estudos
- Insuficiência Cardíaca15 estudos
- Autismo13 estudos
- Leucemia Linfoblástica Aguda13 estudos
- Câncer Colorretal13 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.